September 21, 2006
By:
Maribel Rios
ePT--the Electronic Newsletter of Pharmaceutical Technology
Specialty Pharmaceutical Company Bentley Pharmaceuticals has entered into an agreement with Cardinal Health for the scale-up of clinical supplies for Bentley's intranasal insulin product candidate.
|
April 2, 2007
By:
Yaz Yazicioglu, Emmanuelle Berthemet
Pharmaceutical Technology
Indian pharmaceutical machine manufacturers (IPMMs) are exceptional among their foreign counterparts. Historically similar to the Chinese with regard to copycat practices, patent infringements, and substandard quality, the IPMMs have made great strides in innovation and collaboration to break free from the shackles of this paradigm.
|
June 22, 2006
By:
Kaylynn Chiarello-Ebner
ePT--the Electronic Newsletter of Pharmaceutical Technology
Microsoft Corporation (Redmond, WA) announced the winners of the Microsoft Pharmaceuticals and Life Sciences Innovation Awards 2006 at this year?s meeting of the Drug Information Association in Philadelphia, Pennsylvania. A four-person panel of industry experts selected winners for the innovative use of Microsoft products in pharmaceutical and life sciences business processes and practices.
|
April 2, 2006
By:
Naushad M. Khan Ghilzai
Pharmaceutical Technology
Absorption promoters and enhancers and enzyme inhibitors, either alone or in combination, can play an important role in improving the bioavailability of oral insulin.
|
March 2, 2006
By:
Biswajit Mukherjee, PhD, Surajit Das, Balaram Patra, Buddhadev Layek
Pharmaceutical Technology
Transdermal matrix-type patches of Nefopam hydrochloride with a combination of pressure-sensitive adhesives were developed. The polymeric composition provided a controlled and sustained release of the drug from the patches and demonstrated favorable physicochemical characteristics.
|
June 2, 2005
By:
Maribel Rios
Pharmaceutical Technology
Once considered mainly an afterthought in a company's lifecycle-management strategy, controlled-release dosage forms are now positioned at the forefront of many formulation strategies. In contrast to drug discovery, formulation work focuses not only on the intricacies of the active pharmaceutical ingredient (API), but also on fine-tuning the excipients, the release profile, and the delivery mechanism to provide optimal therapeutic benefit. Because of their wide range of applications and functionalities, especially in controlled-release therapies, polymers are among the most widely used excipients.
|
April 2, 2005
By:
Mark A. Czarnesli
Pharmaceutical Technology
The authors argue that chlorine dioxide
(CD) is a safe and effective decontaminating
agent that can be used for challenging
applications.The effectiveness of CD gas for
sterilizing complex isolator systems is
studied.
|
|
